Guangxiang Pharmaceutical Brand of Shijiazhuang Sihua Pharmaceutical Group Selected for Hebei Province’s Public List of Renowned Consumer Products


Category:

发布时间:2026-02-25

【概要描述】 Recently, the Provincial Department of Industry and Information Technology released the public notice of the proposed list of Hebei Consumer Brand Products for 2025. Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd.’s “Guangxiang” brand was included in the public notice of the 2025 Hebei Consumer Brand Products (Trendsetting New Stars) list. According to reports, the selection of Hebei Province’s Consumer Brand Products is based on the province’s distinctive strengths in the consumer goods industry, focusing on consumer brands that demonstrate independent innovation, high-end quality, and strong reputations. The initiative aims to actively foster regionally advantageous industries and premium brands, thereby accelerating the establishment of a provincial-level roster of distinguished consumer brands. Following enterprise applications and recommendations from municipal industrial and information technology authorities, and after undergoing prescribed procedures—including expert panel reviews, consultation with relevant departments, and specialized research—a total of
Recently, the Hebei Provincial Department of Industry and Information Technology released the public notice of the proposed list of Hebei Consumer Brand Products for 2025. The “Guangxiang” brand of Shijiazhuang Sihua Pharmaceutical Group Hebei Guangxiang Pharmaceutical Co., Ltd. was included on the public notice list for the 2025 Hebei Consumer Brand Products (Trendsetting Newcomer) category.
According to reports, the Hebei Province Consumer Brand Selection initiative is grounded in the province’s distinctive strengths in the consumer goods industry. Focusing on consumer brands that demonstrate independent innovation, high-end quality, and strong reputations, the program actively fosters regionally advantageous industries and premium brands, while accelerating the establishment of a provincial-level roster of renowned consumer brands. Following enterprise applications and recommendations by municipal departments of industry and information technology, and after undergoing prescribed procedures—including expert panel reviews, consultation with relevant authorities, and specialized research—a total of 40 enterprise brands and 12 regional brands have been recommended.
In recent years, Guangxiang Pharmaceutical has placed innovation at the core of its strategy, continuously increasing R&D investment. As a result, a series of new API products have been successively approved for market launch, establishing a robust product portfolio that encompasses both bulk and specialty APIs, with a total of 52 API varieties currently available. Thanks to its uncompromising quality and strong reputation, the company’s flagship product—caffeine—and the enterprise itself have respectively obtained EU CEP certification and China Customs’ AEO Advanced Certification, positioning Guangxiang as a premium supplier to numerous domestic formulation manufacturers. Moreover, its products are exported to more than 60 countries and regions across Europe, North America, Southeast Asia, and beyond, steadily enhancing the brand’s influence and strengthening its market competitiveness.
 
 
 
 
 
 
 
 

Keywords: